Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2846 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Summer Street acquires Willcare

Terms of the transaction were not disclosed, though Summer Street is said to use its aggregate $300 million under management to make equity investments that typically range from

ARYx Therapeutics names new board member

Mr Beier is a veteran of the biotechnology industry and has been instrumental in the development of US public policy impacting biotechnology companies, having served in both the

Pharmos to cease operations in Israel

The research programs in Israel are the CB2 receptor selective library of compounds, including preclinical development of PRS-639,058 for neuropathic pain. Additionally, the company has almost completed a

LMS and AirStrip Technologies sign agreement

Through this relationship, LMS is said to reassert its commitment to provide the best in clinical systems and patient safety programs for labor & delivery while responding to

K2M forays into international spine market

The K2M product portfolio cleared for sale encompasses a full array of products developed to treat complex spinal conditions and includes the Range spinal system, Mesa spinal system,